Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG
|
|
- Damian Boyd
- 5 years ago
- Views:
Transcription
1 Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal patches to ensure that they are correctly stored correctly, administered, recorded and disposed of. These opioids patches are strong opioids e.g fentanyl and buprenorphine. They are available as a self adhesive patch. This allows a standard amount of drug to cross each hour from the patch into the skin and provides a continuous delivery of drug into the body over the duration administration period. All health and social care organisations are accountable for ensuring the safe management of controlled drugs (CD s) within care homes. Organisation within which the SOP applies: All Care homes receiving medicines from community pharmacies and/or whose service users are registered with GP practices within NHS Sutton CCG Objectives / Purpose To ensure that opioid transdermal patches are administered correctly and the administration appropriately witnessed according to CD procedure 26. To ensure that opioid transdermal patches are received, stored, handled and disposed of correctly To ensure w r i t t e n records of all opioids transdermal patch products received, administered and disposed of, are made and kept in a suitable register within the home. To define accountability and responsibilities of individual members and to ensure practice is in line with the regulatory frameworks Scope This Standard Operating Procedure applies to Managers, Nurses and care staff working within Care Homes in NHS Sutton CCG who have responsibility for medicines Responsibilities Staff working in the areas who have a responsibility for the safer management of medicines in care homes within NHS Sutton CCG Related Guidelines and Standing Operational Procedures NHS Oxfordshire Guidelines on the use of Transdermal Fentanyl Patches and NHS Blackburn and Darwen The use of fentanyl patches for severe chronic pain guidance for care homes and domiciliary care. Regulation 13 of the Health and Social Care Act 2008 (Regulated Activities 2009) Regulation 2010 THE HANDLING OF MEDICINES IN SOCIAL CARE Royal Pharmaceutical Society November 2007 The Health and Social Care Act 2008 (regulated activities) Regulations Safe Care and treatment. Regulation 12 NHS PrescQIPP Bulletin 75: Guidelines on the management of controlled drugs (CD) in care homes: December 2014 Review Period
2 January 2019 (or earlier if indicated) Validation process: This guidance has been approved by Sutton and Merton MMC for use in care homes within NHS Sutton Clinical Commissioning Group Author and contributors: Hai To, Care Home Pharmacist, NHS Sutton CCG Acknowledgement: Tania Cook, Specialist Senior Medicines Management Technician Social Care Lead, NHS Nottingham City CCG Date Approved: January 2017
3 Process Actions There are currently 2 different opioids available as transdermal patches. They are fentanyl and buprenorphine. Fentanyl and buprenorphine are CDs and their use must be entered the CD register and stock must be stored in an approved CD cabinet. Further information on controlled drugs is available in Care Home Procedure 26 - Controlled Drugs It is important that disposable gloves are worn by staff applying patches as fentanyl and buprenorphine are extremely potent painkillers, and it is important that staff do not absorb any of the drugs through their skin. The patch should be applied to a clean, dry area of skin which is non hairy; if necessary, the hair may be clipped with scissors but not shaved. Do not apply the patch to irritated, recently irradiated or shaven skin, or on lymphoedematous areas. Press in place firmly with the palm of the hand for 30 seconds. Some patients may need a semi-permeable dressing to ensure adherence. If more than one patch is applied they should be applied at the same time and placed far enough apart so they do not overlap. Refer to the patient information leaflet (PIL) for information as to where the patch may be applied. Service users can bathe or shower (with care) whilst wearing a patch but the water should not be too hot. When a new patch is to be applied, it should not be applied immediately after a bath or a shower or immediately after using creams, talc or soap on the skin. The skin should be completely dry before application of the patch. Remove the old patch before applying a new one. The new patch should be dated and a patch chart used to indicate the date and position of the patch on the resident so that sites can be rotated. It should also be clear on the MAR chart when a service user s patch should be changed Ensure all patches are removed prior to the application of a new patch - it is important to remember that some drug remains in the patch after the duration period specified e.g. 72 hours has elapsed. Overdose may occur if patches are not removed appropriately Ideally the underlying skin should be allowed to rest for 3-6 days before applying another patch to the same area. The site of application should be rotated in accordance with the manufacturer s guidance The patch should be checked each day to ensure that it is still in place. Heat (e.g. hot baths, electric blankets, hot water bottles) should NEVER be applied over the top of the patch as it may enhance the absorption of these drugs and therefore cause the Responsible Person Designated nurse (for nursing clients) or Home Manager/Senior Carer
4 patient to receive a higher dose An increased temperature / fever may also increase absorption and the resident should be monitored for side effects and toxicity. Seek advice from the service user s GP. Site irritation, usually from the adhesive, may necessitate a change of brand and should be discussed with the service user s GP When ordering repeat opioid patches, it is important to ensure the service user has enough for continued therapy but it is also important not to over-order the patches as the dosage of the patch may need to be changed Used patches still contain the drug, therefore it is important to ensure these are disposed off correctly as described below: After removal, fold the patch in half and stuck together with the adhesive sides inwards discard in a sharps bin or, for care homes without nursing, they should return to the supplying pharmacy for destruction Remove gloves and wash hands thoroughly Any unused patches should also be disposed of appropriately in line with the care homes medicines waste disposal procedure 18.
5 Appendix 1: Patch application record Name of resident Date of birth Drug name: Strengths(s): No. of patches: DAY DATE TIME ACTION/COMMENT SIGNATURES Drug name: Strengths(s): No. of patches:
6 The old patch should be removed before applying the new patch. The old patch must be folded in half and stuck together before disposal. The site of application should be rotated in accordance with the manufacturer guidance. Use a cross (x) to indicate where the new patch has been applied. Use a new section each time patches are applied. The patch should be checked on a daily basis to make sure it is still in place.
7 I have read and understood this standard operating procedure and agree to work to it. Name Job Title Signature Date Home Manager
Curraheen, Co.Cork. Disclaimer: The information contained within this policy is accurate and up-to-date at date of approval.
Curraheen, Co.Cork. SOP Title: Management of Transdermal Patches SOP No: 19 Version number: 2 Date of Re-approval: 28 th July, 2015 Revision due: 28 th July, 2018 Index Code No: CLIN041/SOP NO 19 Disclaimer:
More informationWhy do I need to use Fentanyl Patches?
Why do I need to use Fentanyl Patches? Fentanyl patches are used to control on-going moderate to severe pain. They are not used for pain that only lasts for a short time. You will be given different, quick
More informationGuidance on Bulk Prescribing for Care Home Patients
Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity
More informationCare Homes - Homely Remedies Protocol
Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained
More informationGuidance on Bulk Prescribing for Care Home Residents
Guidance on Bulk Prescribing for Care Home Residents There are many residents in care homes taking medicines when required, which may present problems for the prescriber in determining the quantity to
More informationTemplate Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices
Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining
More informationMedication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:
Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe
More informationCare homes - Homely remedies
Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product
More informationProcedure/ Care Plan for Domiciliary Care Workers/ Support Workers Instillation of Ear Drops (Adult)
Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers Instillation of Ear Drops (Adult) CLINICAL GUIDELINES ID TAG Medicines Management Specific Title: Procedure: Instillation of ear drops
More informationMedication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid
Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough
More informationHomely Remedies Guidance for Care Homes
Homely Remedies Guidance for Care Homes What is a homely remedy? Homely or household remedy is another name for a non-prescription medicine which is used in a care home for the short term management of
More informationCare homes - Homely remedies
Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely
More informationBuprenorphine Patch (Transtec Patch)
NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Buprenorphine Patch (Transtec Patch) For the Treatment of Pain Contents Page What is a transtec patch?...
More informationADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME
STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote
More informationINFORMATION FOR THE CONSUMER
INFORMATION FOR THE CONSUMER TRANSDERM-V* and HOW TO USE IT (scopolamine) Transdermal Therapeutic System INTRODUCTION This leaflet is intended to help you understand what TRANSDERM-V* is and how it helps
More informationSAFE HANDLING OF VACCINES
STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers
More informationADMINISTRATION OF INSULIN
STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration
More informationPatient Information. Sancuso [san-koo-so] (granisetron transdermal system)
Patient Information Sancuso [san-koo-so] (granisetron transdermal system) IMPORTANT: For skin use only Read the Patient Information that comes with Sancuso before you start using it and each time you get
More informationCaring for your indwelling urinary catheter
Caring for your indwelling urinary catheter Information for patients This information is produced by the Continence, Urology and Colorectal Service Leeds Community Healthcare NHS Trust Having a urinary
More informationUniversity College Hospital at Westmoreland Street. Urinary sheaths. Urology Directorate
University College Hospital at Westmoreland Street Urinary sheaths Urology Directorate If you would like this document in another language or format, or require the services of an interpreter, contact
More informationGENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY
GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY First issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date August 2018 1.0 Promoting generic prescribing whenever
More informationProcedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult)
Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult) CLINICAL GUIDELINES ID TAG Medicines Management Specific Title: Procedure: Assisting
More informationPatient information. How to use your Fluorouracil 5FU 1% Eye Drops St Paul s Eye Unit PIF 539 V6
Patient information How to use your Fluorouracil 5FU 1% Eye Drops St Paul s Eye Unit PIF 539 V6 You have been prescribed 5FU eye drops to treat your eye condition. 5FU is a cytotoxic agent, which can
More informationPrescription only medicines (POMs)
Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations
More informationOpioid Type Pain Killers
Opioid Type Pain Killers Information for patients, relatives and carers For more information, please contact: Palliative Care Team 01904 725835 (York) 01723 342446 (Scarborough) Renal Department 01904
More informationOpioids in Palliative Care
Opioids in Palliative Care Brooke Building Palliative Care Team 0161 206 4609 All Rights Reserved 2017. Document for issue as handout. What are strong opioids? Strong opioids are painkillers which are
More informationLong Term Care Formulary HCD - 08
1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally
More informationHOW TO USE YOUR INSTANYL MULTI-DOSE NASAL SPRAY
HOW TO USE YOUR INSTANYL MULTI-DOSE NASAL SPRAY Important SAFETY information about instanyl Familiarise yourself with this important information and make sure you read the Package Leaflet that comes with
More informationAPPENDIX 1 PROCEDURES FOR ADMINISTERING MEDICATION
APPENDIX 1 PROCEDURES FOR ADMINISTERING MEDICATION 1. Wash and thoroughly dry hands and any utensil that may be required e.g. medicine spoon, measure, glass, tablet cutter 2. Where a clinical tasks protocol
More informationPATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)
PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system) If you have Restless Legs Syndrome (also known as Willis-Ekbom disease), read this side. If you have Parkinson s disease, read the other
More informationDUTRAN Transdermal Drug Delivery System
DUTRAN Transdermal Drug Delivery System contains the active ingredient fentanyl Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about DUTRAN. It does not
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationLidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy
Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel Information for patients Pharmacy This leaflet contains important information about your medicine; please read it carefully. If you
More informationGood Practice Guidance on Covert Administration of Medication
Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their
More informationQ&A: Opioid Prescribing for Chronic Non-Malignant Pain
NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer
More informationDisclosure. Being a medical caregiver means putting your self in suffering s way. Prescribing opioids The pain that won t go away
Prescribing opioids The pain that won t go away Dennis Boyle, M.D COPIC 2016 Disclosure I have no relevant financial relationships to disclose Being a medical caregiver means putting your self in suffering
More informationMy Urinary Catheter Passport Looking after my urinary catheter
Feedback We welcome your comments. If you have any ideas about how we could do something better or feedback about positive aspects of the service please let us know. If you have a complaint please let
More informationUrinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition
Urinary Catheter Passport A guide to looking after a urinary catheter (for service users and healthcare workers) 2nd Edition Contact details Urinary Catheter Passport Service user Name Address Postcode
More informationSorafenib (Nexavar ) ( sor-af-e-nib )
Sorafenib (Nexavar ) ( sor-af-e-nib ) How the drug is given: by mouth Purpose: To stop the growth of cancer cells in kidney cancer, liver cancer, and other cancers How to take the drug by mouth Take on
More informationJylamvo 2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals. Information to minimise the risk of medication error
2 mg/ml oral solution (Methotrexate) Guide for Healthcare Professionals Information to minimise the risk of medication error NOTE: Special warnings and precautions for use - This oral solution contains
More informationHOW TO USE YOUR INSTANYL SINGLE-DOSE NASAL SPRAY
HOW TO USE YOUR INSTANYL SINGLE-DOSE NASAL SPRAY HOW TO USE YOUR INSTANYL IMPORTANT INFORMATION ABOUT instanyl Familiarise yourself with this important information and make sure you read the Package Leaflet
More informationMedications. Managing and Administering Medication
Medications Managing and Administering Medication The Medication Administration Checklist Administering medications is an important and vital responsibility. It is important to make sure that no errors
More informationCaring for a person with a stoma and dementia
Caring for a person with a stoma and dementia www.colostomyuk.org Freephone helpline: 0800 328 4257 Caring for a person with a stoma and dementia Colostomy UK We are Colostomy UK. Here if you have questions,
More informationHomely Remedies Guidance
Homely Remedies Guidance Guidance from the Royal Pharmaceutical Society of Great Britain (RPSGB) in The Handling of Medicines in Social Care, states that care homes are able to purchase medicines for use
More informationGood Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes
Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes This good practice guidance is intended to be used as a framework for care home managers to adapt when writing their
More informationNetwork Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug
Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug West Midlands Expert Advisory Group for Systemic Anti-Cancer Therapy (SACT) Page 1 of 8 West Midlands Clinical Networks and
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationCommunity Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines
Community Pharmacy Enhanced Service Just In Case 4 Core Drugs supply Stock Holding of Palliative Care Medicines Parties to the Agreement Provider: Purchaser: NHS Blackpool 1. Service description 1.1 This
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix)
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix) Read this carefully before you start taking Fentanyl Patch and
More informationUnit 204 Assist with the assembly of prescribed items
Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination
More informationPatient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet
Page 1 of 6 Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet What type of drug is it? BuTrans transdermal patches
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes
The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April
More informationquestions about why this medicine has been prescribed for you.
Transdermal System Fentanyl Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about patches. It does not contain all the available information. It does not
More informationYou have high risk feet
You have high risk feet diabetes information and advice leaflet Emergency Action Plan FOOT ATTACK? If your foot is red, swollen or if you have skin breakdown RING 07786250788 IMMEDIATELY. Emergency Department
More informationProcedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE
Written By: Objective By: ed By: To ensure safe and consistent working practice throughout Black Country Partnership Foundation Trust (BCPFT) and to avoid unnecessary harm to patients on lithium therapy
More informationRadical Orchidectomy. Department of Urology. Patient Information
Radical Orchidectomy Department of Urology 2 Patient Information This leaflet answers some of the questions people ask about a radical orchidectomy operation. If any further questions are raised after
More informationBefore you use DENPAX. When you must not use it
Denpax Transdermal System contains the active ingredient fentanyl CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about. It does not contain all the available
More informationQutenza (Capsaicin) 8% patch
Qutenza (Capsaicin) 8% patch Exceptional healthcare, personally delivered Pain is transmitted by nerves so it is often possible to reduce pain by blocking signals from affected nerves. What is Qutenza?
More informationISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS
ISOPA PRODUCT STEWARDSHIP PROGRAMMES Walk the Talk MDI USERS 1 2 Walk the Talk - MDI Users Content Essential data Good practice When things go wrong... Dialogue 3 MDI Classification Harmful by inhalation
More informationAdministration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure
Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September
More informationCoversheet for Network Site Specific Group Agreed Documentation
Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance
More informationPART III: CONSUMER INFORMATION ABOUT THIS MEDICATION. APO-FENTANYL MATRIX fentanyl transdermal system
PART III: CONSUMER INFORMATION APO-FENTANYL MATRIX fentanyl transdermal system This leaflet is Part III of a three-part "Product Monograph" published when APO-FENTANYL MATRIX was approved for sale in Canada
More informationBest Practice Guidance 12_Version 1.2. Title: Collection of Biological Samples
This document is for guidance on the collection of biological samples that have been granted ethical approval under CUREC procedures. Certain research involving the taking of samples that consist of, or
More informationRadiotherapy treatment to your breast buds
Acute Services Directorate Information for patients receiving Radiotherapy treatment to your breast buds This leaflet is for patients with prostate cancer who will have radiotherapy to their breast buds
More informationPackage leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin
Package leaflet: Information for the user Qutenza 179 mg cutaneous patch capsaicin Read all of this leaflet carefully before you start using this medicine because it contains important information for
More informationMedicines for Self Care Policy
Document purpose This policy describes the commissioning decision for medicines for self-care made by NHS Mansfield and Ashfield CCG and NHS Newark and Sherwood CCG. Version Version 1.0 Final Title Associated
More informationLatex and Occupational Dermatitis Policy Incorporating Glove Selection
Latex and Occupational Dermatitis Policy Incorporating Glove Selection DOCUMENT CONTROL: Version: 3 Ratified by: Risk Management Sub Group Date ratified: 17 July 2013 Name of originator/author: Health
More informationDabrafenib (Tafinlar )
Dabrafenib (Tafinlar ) ( da-braf-e-nib ) How drug is given: By mouth Purpose: To stop the growth of cancer cells in melanoma and other cancers. How to take this drug Take this medication on an empty stomach
More informationA patient guide to the use of insulin for diabetes
A patient guide to the use of insulin for diabetes Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationSummary of Product Characteristics
Summary of Product Characteristics Product Summary 1. Trade Name of the Medicinal Product Durogesic DTrans 12/25/50/75/100 Transdermal Patch 2. Qualitative and Quantitative Composition Each Durogesic DTrans
More informationPatient Group Directions Policy
Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This
More informationThe Safe Collection and Disposal of Drug Related Litter in the Community
The Safe Collection and Disposal of Drug Related Litter in the Community Document Type Protocol Issue date April 2012 Review date April 2014 Distribution Prepared by Scottish Borders Council, Registered
More informationNitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate
Package leaflet: Information for the user Nitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate Read all of this leaflet carefully before you start using this medicine because it
More informationDocument Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the
Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis
More informationTOP TIPS NHS COMMUNITY PHARMACY FLU VACCINATION SERVICE
TOP TIPS NHS COMMUNITY PHARMACY FLU VACCINATION SERVICE Top Tips NHS Community Pharmacy - Flu Vaccination Service ENSURE YOU ARE TRAINED AND COMPETENT TO DELIVER THE FLU SERVICE On 20th July 2015, PSNC
More informationWhere do you get most of your information about medications?
DRUG ACTION AND RLS Jacquelyn Bainbridge, Pharm.D., FCCP Professor Pei Shieen Wong, Pharm.D., BCPS University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences,
More informationInformation and instruction for Home Helps caring for clients with indwelling urinary catheters
Information and instruction for Home Helps caring for clients with indwelling urinary catheters This leaflet provides you with information and instructions on caring for clients who have an indwelling
More informationCoping with tummy bugs. Advice for parents/carers on dealing with an episode of diarrhoea and/or vomiting
Coping with tummy bugs Advice for parents/carers on dealing with an episode of diarrhoea and/or vomiting www.dettol.co.uk www.unitetheunion.org/cphva Looking after your child, Healthy hygiene With over
More informationPackage leaflet: Information for the user. Fetanex 12.5 microgram/hour Transdermal Patch Fetanex 37.5 microgram/hour Transdermal Patch.
Package leaflet: Information for the user Fetanex 12.5 microgram/hour Transdermal Patch Fetanex 37.5 microgram/hour Transdermal Patch Fentanyl Read all of this leaflet carefully before you start using
More informationquestions about why this medicine has been prescribed for you.
Transdermal System Fentanyl Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about patches. It does not contain all the available information. It does not
More informationShropshire s Continence Advisory Service INDWELLING URINARY CATHETERS
Shropshire s Continence Advisory Service INDWELLING URINARY CATHETERS Information for Patients and Carers F:\CONTINENCE\Acute Urianary Retention\04-12\005- Indwelling Urinary Cathter Leaflet - A4-13-02-09.doc
More informationPATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)
PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system) If you have Parkinson s disease, read this side. If you have Restless Legs Syndrome (also known as Willis-Ekbom disease), read the other
More informationCataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives
NHS Dorset Clinical Commissioning Group Cataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives 1. INTRODUCTION AND SCOPE NHS DORSET CLINICAL COMMISSIONING GROUP
More information2.2 Blood sampling can be done for various tests depending on the clinical research study.
Document Number: SOP/07/V3 Title: Obtaining a Blood Sample (capillary) in children and young people Author: Liz Waxman Version 3 Effective Date: 16/5/2014 Periodic Review Date: 15/5/2017 Superseded version
More informationfor adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services
The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service
More informationWhat is a Leaderflex catheter?
Leaderf lex How to care for your catheter patient gu ide www.vygon.co.uk vygon@vygon.co.uk This booklet will give you information about the care your catheter and things to look out for. For any other
More informationCONSENT FORM UROLOGICAL SURGERY
CONSENT FORM for UROLOGICAL SURGERY (Designed in compliance with consent form 1) PATIENT AGREEMENT TO INVESTIGATION OR TREATMENT Patient Details or pre-printed label Patient s NHS Number or Hospital number
More informationMedication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016
Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply
More informationDate First Issued: Date of Last Review: Date of Next Review: Version Number: 1.0
Document Type: Policy Area: Document Title: Policy Educlear FIRST AID Date First Issued: 01.10.2016 Date of Last Review: 01.10.2016 Date of Next Review: 01.10.2017 (minimum policy review to be within 2
More informationEndovenous ablation treatment of varicose veins under local anaesthetic
Patient information: Endovenous varicose vein treatment (LA) Endovenous ablation treatment of varicose veins under local anaesthetic Introduction The vascular consultant (doctor specialising in veins and
More informationMRSA. Meticillin Resistant Staphylococcus aureus. Infection Control Department. Royal Surrey County Hospital. Patient information leaflet
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust MRSA Meticillin Resistant Staphylococcus aureus Infection Control Department This leaflet has been written to help you understand
More informationISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS
ISOPA PRODUCT STEWARDSHIP PROGRAMMES Walk the Talk MDI USERS Revision 2017 1 ISOPA Member Companies Walk the Talk - MDI Users Content Essential data Good practice When things go wrong... Dialogue 3 MDI
More informationNorth of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines
\ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents
More informationCatheter Passport. Guide for male and female patients and their carers. Please keep it safe.
Catheter Passport Guide for male and female patients and their carers Please keep it safe. 20 1 Introduction The purpose of this booklet is to give you advice on looking after your urinary catheter. If
More informationMedicines which should not be regularly prescribed in primary care. Consultation. Information booklet
Medicines which should not be regularly prescribed in primary care Consultation Information booklet About this document When we say primary care, we mean the medical services that people go to first. These
More informationUsers of this standard will need to ensure that practice reflects up-to-date information and policies.
About this Unit This standard relates specifically to the insertion of intravenous cannula to facilitate access to the blood system for treatment or diagnostic purposes. Access may be required for serial
More informationPOLICY MEDICAL POLICY RE: INFECTION CONTROL. This policy applies to all School departments, including EYFS
POLICY MEDICAL POLICY RE: INFECTION CONTROL This policy applies to all School departments, including EYFS The transmission of the common cold, Influenza and more volatile viruses such as the Rotovirus
More informationFencino patch (5) 2. Check the practice has agreed to the protocol and a signed copy is in place.
Switch protocol: Fentanyl/Durogesic patches to Fencino /Matrifen /Mezolar brand switch Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the
More information